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Mitral Annular Plane Systolic Excursion and Tricuspid Annular
Plane Systolic Excursion in Cats with Hypertrophic Cardiomyopathy
I. Spalla, J.R. Payne, K. Borgeat, A. Pope, V. Luis Fuentes, and D.J. Connolly
Background: Left ventricular (LV) systolic dysfunction is associated with increased risk of death in cats with hypertrophic
cardiomyopathy (HCM). Mitral and tricuspid annular plane systolic excursion (MAPSE and TAPSE, respectively) are mea-
sures of longitudinal systolic function and are reduced in human patients with HCM.
Hypotheses: Cats with HCM have lower MAPSE and TAPSE compared to control cats; lower MAPSE and TAPSE are
associated with the presence of congestive heart failure (CHF) and reduced survival time.
Animals: 64 cats with HCM and 27 healthy cats. Forty-five cats with HCM were not showing clinical signs, and 19 had
CHF.
Methods: Retrospective study. Anatomic M-mode from the left apical 4-chamber view was used to record MAPSE from
the free wall (MAPSE FW) and septum (MAPSE IVS) and TAPSE.
Results: Compared to controls, cats with HCM had lower MAPSE IVS (controls 5.2 [4.6–5.6] mm, asymptomatic HCM
4.7 [4.1–5.2] mm, HCM with CHF 2.6 [2.5–3.2] mm, P < .001), MAPSE FW (controls 5.9 [5.3–6.2] mm, asymptomatic HCM
4.7 [4.1–5.1] mm, HCM with CHF 2.8 [2.4–3.2] mm) and TAPSE (controls 8.6 [7.4–10.2] mm, asymptomatic HCM 7.2 [6.3–
8.2] mm, HCM with CHF 4.6 [4.1–5.4] mm), with the lowest in the CHF group. Univariate survival analysis showed a
shorter survival in cats displaying lower MAPSE IVS, MAPSE FW, and TAPSE.
Conclusions and Clinical Importance: MAPSE and TAPSE were lower in cats with HCM than in control cats and were
lowest in CHF, suggesting that systolic longitudinal dysfunction is present in cats with HCM. MAPSE and TAPSE have
potential prognostic significance.
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Hypertrophic cardiomyopathy (HCM) is the mostcommon heart disease in cats.1,2 It is characterized
by a hypertrophied left ventricle in the absence of other
cardiovascular or systemic causes.3 Recently, it has been
reported that increased right ventricular wall thickness
is common in cats with HCM and related to the sever-
ity of left ventricular hypertrophy.4 Cats with HCM can
have variable life expectancy; several clinical and
echocardiographic prognostic factors including left
atrial (LA) size and function, extreme left ventricular
hypertrophy, measures of left ventricular systolic and
diastolic function, presence of congestive heart failure,
and aortic thromboembolism have been associated with
decreased survival in cats with HCM.5–9
Mitral annular plane systolic excursion (MAPSE) and
the right-sided counterpart tricuspid annular plane sys-
tolic excursion (TAPSE) are M-mode-derived indices of
systolic longitudinal displacement of the atrioventricular
annular plane.10,11 MAPSE and TAPSE can therefore
be considered as markers of left ventricular (LV)10,12
and right ventricular (RV)11,13 long-axis function,
respectively. It is recognized, however, that left-sided
heart disease can also influence TAPSE.14,15
Currently, there are no published reference values for
MAPSE and TAPSE in cats and no information on
their potential diagnostic and prognostic utility in
HCM.
Study Aims
1 To provide preliminary reference intervals for
MAPSE and TAPSE in healthy cats.
2 To determine whether cats with HCM have lower
values of MAPSE and TAPSE compared to control
cats and whether lower MAPSE and TAPSE are
associated with the presence of CHF.
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Abbreviations:
LA/Ao left atrial-to-aortic root ratio
LAD left atrial diameter in long axis
LAFS left atrial fractional shortening
LVFS left ventricular fractional shortening
MAPSE mitral annular plane systolic excursion
S0 FW tissue Doppler-derived S0 wave at the left ventricular
free wall
S0 IVS tissue Doppler-derived S0 wave at the interventricular
septum
TAPSE tricuspid annular plane systolic excursion
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3 To investigate whether lower values of MAPSE or
TAPSE have prognostic value in cats with HCM.
Materials and Methods
Retrospective study. The electronic patient record of the Queen
Mother Hospital for Animals (QMHA) was reviewed for cats
diagnosed with HCM between April 2013 and September 2015.
The control group comprised healthy cats undergoing cardiac
assessment as part of blood donor program.
To be included in the study, a complete case record (owner
data, cat/donor signalment and history, complete physical exami-
nation, and current medications) and a complete echocardio-
graphic examination were required. An additional inclusion
criterion was a left apical 4-chamber cineloop of adequate quality
to measure MAPSE and TAPSE.
Exclusion criteria included cats diagnosed with other conditions
that could affect LV wall thickness such as hyperthyroidism, sys-
temic hypertension, acromegaly, cardiomyopathies other than
HCM, congenital heart disease, or neoplastic disease, or those
with incomplete case record or echocardiographic examination.
A complete standard echocardiographic examination including
M-mode, B-mode, and Doppler echocardiography was performed
in all cats in accordance with published human and veterinary
guidelines for human and veterinary medicine.11,16
Cats were diagnosed with HCM when end-diastolic left ventric-
ular wall thickness measured in B-mode was equal to or greater
than 6 mm. In addition, LA size and function were assessed by
measuring left atrium-to-aorta ratio (LA/Ao) at the onset of
QRS,8,17 left atrial diameter in long axis (LAD)8,17 measured at
end systole and left atrial fractional shortening (LAFS).8 Left ven-
tricular systolic function was assessed by left ventricular fractional
shortening (LVFS) on M-mode.8 Where available, the S0 wave of
the interventricular septum (S0 IVS) and left ventricular free wall
(S0 FW) were measured from mitral annular septal and free wall
tissue Doppler imaging (TDI), respectively.11,12,18
Cats with HCM were classified as asymptomatic if they were
not receiving any cardiac medication and had no signs or history
of increased respiratory rate, dyspnea, syncope, or systemic throm-
boembolism.
To be included in the CHF group, cats had to have increased
respiratory rate, abnormal thoracic auscultation, and evidence of
pulmonary edema or pleural effusion by imaging (either thoracic
ultrasound or thoracic radiography) at the time of presentation at
QMHA. The full echocardiographic examination occurred no later
than 24 hours after admission following stabilization where neces-
sary. All echocardiographic examinations were performed by a
board-certified veterinary cardiologist or a resident under the
supervision of a specialist cardiologist.
Off-line measurements of MAPSE and TAPSE were performed
by anatomic M-modea from the left apical 4-chamber view as
described in human guidelines and dogs.10–12,19,20 Briefly, the
anatomic M-mode cursor was aligned parallel to the interventric-
ular septum (for MAPSE IVS), free wall (for MAPSE FW), or
the right ventricular free wall (for TAPSE), and an M-mode trac-
ing was obtained. Both MAPSE and TAPSE were measured in
mm with electronic calipers between the most basilar position of
the tricuspid annulus in end diastole and its most apical displace-
ment at end systole by the leading edge method (Fig 1). All
TAPSE and MAPSE measurements were performed by a single
observer (IS). Five consecutive measurements were performed
and the results were averaged. Intra- and interobserver variability
for the acquisition of the anatomic M-mode image and subse-
quent measurement was assessed in a randomly selected 10% of
the population. Measurements for intraobserver repeatability
were performed by a single observer (IS) on 2 occasions 1 week
apart from each other. Measurements for interobserver
repeatability were performed independently by 2 observers (IS
and JRP).
Survival information for the cats diagnosed with HCM was
obtained by reviewing the electronic clinical archive and by contact-
ing referring veterinarians. All-cause mortality was the end-point in
the survival analysis. Cats still alive were censored in the statistical
analysis; subjects lost to follow up were included in the survival
analysis up until the last time point at which they were known to be
alive and then were thereafter censored in the analysis.
Statistical Analysis
Statistical analysis was performed by a commercially available
statistical softwareb , and in all cases, statistical significance was
set at P < .05. The Shapiro-Wilk test was used to verify normal
Fig 1. Technique to acquire and measure MAPSE and TAPSE
by M-mode from the 4-chamber left apical view. See text for
details.
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distribution of variables. Non-normally distributed data are
reported as median (interquartiles range, IQR1-3, 25th percentile
to 75th percentile).
Mann-Whitney U or Kruskal-Wallis test was used to compare
ordinal and continuous, non-normally distributed data as appro-
priate. Posthoc comparisons were performed by Dunn’s method.
For the repeatability study, intra- and interobserver coefficients
of variation (CV) were calculated and Bland-Altman plots were
obtained.
Reference intervals were calculated based on 90% confidence
intervals, as recommended for normally distributed populations
with 20–40 individuals.21
Survival was calculated as the days between diagnosis and death
or last visit. The Kaplan-Meier method was used to estimate sur-
vival function and plot time to event curves in the different
groups. Continuous variables were explored by division into
groups based on tertiles. A log-rank test with right censoring was
used to determine whether a significant difference existed among
groups.
Results
From April 2013 to September 2015, 100 cats were
diagnosed with left ventricular hypertrophy. After
exclusion for concurrent systemic disease (n = 22), lack
of a suitable 4-chamber apical cineloop (n = 8) or both
(n = 6), 64 cats with HCM were included in the study.
Of these 64 cats, 45 were asymptomatic and 19 had
CHF. The control group comprised 27 healthy blood
donor cats.
The median age of the population was 5.6 (3.8–7.0)
years, and the median body weight was 4.6 (4.2–5.0) kg.
There were 56 males and 35 females. The majority of
cats were domestic shorthairs (n = 61), followed by
Bengals (n = 6), Persians (n = 6), and Domestic Long
Hairs (n = 5). Other breeds included were British Short
Hairs and Ragdolls (n = 3), Maine Coons, Scottish
Fold and Birman (n = 2), Selkirk Rex (n = 1).
Reference intervals were generated for healthy control
cats (Table 1).
There was no significant difference between controls
and cats with HCM with regard to age (P = .15), sex
(P = .45), body weight (P = .46), or LVFS (P = .45).
Cats with HCM had larger LAD (P < .001) and LA/
Ao (P < .001) than control cats. Cats with HCM had
lower LAFS (P < .001), TAPSE (P < .001), MAPSE
IVS (P < .001), MAPSE FW (P < .001), S0 IVS
(P = .037), and S0 FW (P < .001) than controls
(Table 2).
When comparing control cats, asymptomatic cats
with HCM, and cats with HCM and CHF, cats with
HCM and CHF had significantly lower MAPSE IVS,
MAPSE FW, and TAPSE than asymptomatic cats with
HCM (P < .001, P < .001, and P < .001, respectively)
and significantly lower MAPSE IVS, MAPSE FW, and
TAPSE (P < .001, P < .001, and P < .001, respectively)
than healthy control cats. Asymptomatic cats with
HCM had a significantly lower MAPSE IVS (P < .001),
MAPSE FW (P < .001), and TAPSE (P < .001) com-
pared to healthy control cats (Figs 2-4, Table 2).
At the end of the study period, 38 of the 64 cats with
HCM were still alive, 6 were lost to follow up, and 20
had died. At the univariable level, increased LAD and
LA/Ao and decreased LAFS, MAPSE IVS, MAPSE
FW, and TAPSE (Table 3, Figs 4-7) were all associated
with reduced survival times.
Intra- and interobserver coefficient of variation
showed good repeatability for acquisition and measure-
ment of MAPSE and TAPSE (Table 4) with minimal
bias (Figs 8-10).
Discussion
The results of our study indicated that cats with
HCM have lower MAPSE and TAPSE values as com-
pared to healthy control cats. Furthermore, cats with
CHF showed the lowest values of MAPSE and TAPSE.
Although the number of cats in the analysis was small,
lower MAPSE and TAPSE were also associated with a
decreased survival time for all-cause mortality, suggest-
ing potential prognostic value. Further studies with a
greater number of cats should enable a greater appreci-
ation of the prognostic utility of MAPSE and TAPSE
for both cardiac and all-cause mortality. The intra- and
interobserver CV as well as the Bland-Altman limits of
agreement indicated that the technique is easily achiev-
able and repeatable among different observers.
Shortening of the left ventricle in the longitudinal
axis is one of the major components of cardiac contrac-
tion as the heart base displaces toward the apex.
MAPSE and TAPSE measure the longitudinal displace-
ment of the annular plane during the cardiac cycle
and can therefore be considered as markers of systolic
long-axis function. It has been estimated that the contri-
bution of longitudinal contraction as assessed by atri-
oventricular plane displacement is responsible for up to
60% of the total cardiac stroke volume in healthy
human adults.22 A decrease in longitudinal function has
been identified by speckle-tracking echocardiography in
the early stages of HCM in people.23,24 Furthermore,
MAPSE measured by MRI is decreased in people with
obstructive and nonobstructive HCM and correlates
with the presence of fibrosis as assessed by late gadolin-
ium enhancement.25
Similarly, the findings of our study indicate that cats
with HCM have lower MAPSE compared to normal
cats, confirming reduced systolic longitudinal function
even in those cats not showing clinical signs. This paral-
lels the findings in human medicine.23,24
Left ventricular functional abnormalities might be
expected in cats with HCM, but our study showed that
RV longitudinal displacement is also reduced in cats
Table 1. Distribution of data for MAPSE and TAPSE
in 27 healthy cats.
MAPSE FW MAPSE IVS TAPSE
Mean (mm) 5.89 5.22 9.02
Standard deviation 0.65 0.59 2.18
Reference interval (90%
confidence interval)
5.67–6.12 5.02–5.43 8.27–9.77
Minimum 4.90 4.20 5.20
Maximum 7.30 6.30 13.40
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with HCM. This parallels findings in people with
HCM, where a decrease in TAPSE has been docu-
mented.15 It remains unclear whether the decrease in
TAPSE can be purely attributed to concomitant right
ventricular cardiomyopathy, which has been identified
in one-third of human patients and about half of cats
with HCM.4,26 Alternatively left-sided heart disease
may provoke right ventricular dysfunction through a
number of pathophysiological mechanisms including the
development of pulmonary hypertension,27,28 reduction
in right ventricular compliance due to ventricular inter-
dependence,15,28 or cause detrimental alteration in right
ventricular coronary perfusion pressure. One or more of
these mechanisms may explain the reduction in TAPSE
identified in this study.12,15,27,28
In this report, cats with CHF had the lowest values
for MAPSE and TAPSE, which probably reflects dis-
ease progression and worsening systolic dysfunction. A
similar finding was reported for LVFS in cats with
more advanced disease.8,9
Furthermore, cats in the lowest tertile for each of
MAPSE IVS, MAPSE FW, and TAPSE were more
likely to reach the final end-point of all-cause mortality,
suggesting that these echocardiographic parameters
have potential prognostic value. Left atrial size and
function was also shown to be of prognostic importance
in our population, as identified in previous studies.6–9
Because of the low number of events, it was not pos-
sible to assess the prognostic utility of these variables
for cardiac mortality and there were too few events to
Fig 2. Box and whiskers plot for MAPSE FW in control cats,
asymptomatic cats with HCM, and cats with HCM and CHF.
Fig 3. Box and whiskers plot for MAPSE IVS in control cats,
asymptomatic cats with HCM, and cats with HCM and CHF.
Fig 4. Box and whiskers plot for TAPSE in control cats, asymp-
tomatic cats with HCM, and cats with HCM and CHF.
Table 3. Univariable survival analysis. Median
survival time (MST) and ranges are displayed. Bold
values indicate statistically significant results.
Variables Tertiles Median survival time P value
LAD <15.1 mm >2884 day (0–2884 day) <.001
15.1–18.8 mm >1748 day (0–1748 day)
>18.8 mm 257 day (0–1865 day)
LA/Ao <1.4 mm >1748 day (0–1748 day) <.001
1.4–1.9 mm >2884 day (0–2884 day)
>1.9 mm 500 day (0–1865 day)
LAFS <20.2% 160 day (0–500 day) <.001
20.2–27.3% 208 day (12–1014 day)
>27.3% >2884 day (0–2884 day)
LVFS <44.0% 500 day (0–1086 day) .093
44–58.4% >2884 day (0–2884 day)
>58.4% 1014 day (0–1139 day)
MAPSE FW <3.3 mm 255 day (0–1016 day) <.001
3.3–4.8 mm >1748 day (0–1748 day)
>4.8 mm >2884 day (0–2884 day)
MAPSE IVS <3.3 mm 580 day (0–1016 day) .002
3.3–4.7 mm >1865 day (0–1865 day)
>4.7 mm >2884 day (0–2884 day)
TAPSE <5.3 mm 500 day (0–1016 day) <.001
5.3–7.2 >1086 day (0–1086 day)
>7.2 >2884 day (0–2884 day)
S0 FW <4.6 1014 day (0–1865 day) .167
4.6–6.5 >1139 day (0–1139 day)
>6.5 >2884 day (0–2884 day)
S0 IVS <6.0 >1865 day (12–1865 day) .110
6.0–9.0 >1748 day (0–1748 day)
>9.0 >2884 day (0–2884 day)
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Fig 5. Kaplan-Meier survival curve for MAPSE FW. Log-rank test, P < .001. Median survival time for MAPSE FW <3.3 mm is 255 days
(0–1016 day); for MAPSE FW 3.4–4.7 mm, median survival time is >1748 days (0–1748 day); for MAPSE FW >4.8 mm, median survival
time is >2884 day (0–2884 day).
Fig 6. Kaplan-Meier survival curve for MAPSE IVS. Log-rank test, P = .002. Median survival time for MAPSE IVS <3.3 mm is 580 days
(0–1016 day); for MAPSE IVS 3.4–4.7 mm, median survival time is >1865 days (0–1865 day); and for MAPSE >4.8 mm, median survival
time is >2884 days (0–2884 day).
Fig 7. Kaplan-Meier survival curve. Log-rank test, P value <.001. Median survival time for TAPSE I < 5.3 mm is 500 days (0–1016 day);
for TAPSE 5.4–7.2 mm, median survival time is >1086 days (0–1086 day); and for TAPSE >7.3 mm, median survival time is >2884 days
(0–2884 day).
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perform multivariable analysis for a final model of sur-
vival. That said, these preliminary findings are encour-
aging and in agreement with a recent study which
showed that right ventricular dysfunction based on
TAPSE was independently associated with an increased
likelihood of death or transplantation15 and therefore
warrant further study with a greater number of cats.
Both MAPSE and TAPSE are techniques that do not
require special expertise or advanced echocardiographic
imaging techniques and are easy to obtain and measure
after minimal training.10 These techniques have the
added advantage that there is no major negative effect
of apical fore-shortening as the measurements are taken
at the AV plane. There are more advanced techniques
to assess longitudinal function such as tissue Doppler
imaging (TDI) or speckle-tracking echocardiography
(STE), but they require advanced and more expensive
software, generally low heart rates, high frame rates,
and adequate image quality. They are also associated
with a steeper learning curve.10
To the authors’ knowledge, no reference intervals of
MAPSE and TAPSE have been published for cats. In
dogs, a curvilinear relationship was found between
TAPSE and weight, which became linear once weight
was normalized to a scale of 1/3.19 Cats may vary in
weight but this is generally less pronounced compared
to dogs, where body weight has a substantial breed-
dependent variation; however, as standard echocardio-
graphic parameters vary with body weight,29 the
authors recommend that the preliminary MAPSE and
TAPSE values provided in this study are applicable in
cats with a body weight between 3.7 and 5.2 kg. Fur-
ther studies are needed to establish the extent of
MAPSE and TAPSE variation based on weight- and
breed-related differences in cats.
The present study has some limitations. First of all,
being a retrospective study, it was not possible to mea-
sure TAPSE from a left apical view optimized for the
right ventricle in all cases. As with all techniques need-
ing a good alignment, MAPSE and TAPSE measure-
ment may be hindered by a degree of malalignment;
however, we were able to minimize this by the use of
anatomic M-mode which enabled us to achieve accept-
able intra- and interobserver CV. However, further vali-
dation of the day-to-day variability in these
longitudinal function indices is justified to further assess
their accuracy and reproducibility in prospective studies.
This study did not attempt to establish correlations
among MAPSE, TAPSE, and other echocardiographic
measures of disease severity such as atrial and ventricu-
lar size and function or invasive catheterization data,
for instance, to determine presence and severity of pul-
monary hypertension. Interestingly, it has been shown
in human patients with HCM that right ventricular
Table 4. Intra- and interobserver CV for MAPSE and
TAPSE.
CV Intraobserver (1) (%) Interobserver CV (%)
MAPSE FW 2.0 8.0
MAPSE IVS 1.6 8.0
TAPSE 1.5 5.0
Fig 8. Bland-Altman Plot for MAPSE FW. Mean bias 0.01
(0.27 to 0.244) mm.
Fig 9. Bland-Altman Plot for MAPSE IVS. Mean bias 0.06
(0.69 to 0.82) mm.
Fig 10. Bland-Altman for TAPSE. Mean bias 0.18 (1.04 to
1.40) mm.
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dysfunction measured by TAPSE was independently
associated with the degree of left ventricular diastolic
and systolic dysfunction and pulmonary hypertension.15
Furthermore, we did not evaluate the influence of medi-
cations such as furosemide on echocardiographic
parameters, which through reduction in preload may
influence longitudinal function. Due to the low number
of events, we were unable to perform a multivariable
survival analysis and further studies are needed to con-
firm our preliminary survival findings and to assess
whether MAPSE and TAPSE have prognostic value for
cardiac mortality.
The authors tried to exclude all possible secondary
causes of left ventricular hypertrophy based on the
available data for each case. However due to the retro-
spective nature of the study and the challenges associ-
ated with a final confirmation of myocarditis, we
cannot completely rule out the possibility that cats with
rare causes of LVH such as transient myocarditis were
included in the study. Finally, due to the retrospective
nature of the study, it was not possible to blind the
investigator performing echocardiographic measure-
ments to the clinical diagnosis of the cats, which may
have introduced bias into our results.
In conclusion, cats with HCM had lower MAPSE IVS,
MAPSE FW, and TAPSE, with the lowest values in cats
with CHF. Furthermore, our preliminary data indicated
that cats with MAPSE below 3.3 mm and TAPSE below
5.3 mm had reduced survival times. Importantly, the
technique was found to be feasible in the majority of cats
with acceptable intra- and interobserver CV.
Footnotes
a Vivid 7 with Echo Pac off-line measurement software, GE sys-
tems, Hatfield, UK
b IBM SPSS Statistics version 22, IBM (UK) Ltd, Portsmouth,
UK
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